Cargando…

CEBPG suppresses ferroptosis through transcriptional control of SLC7A11 in ovarian cancer

BACKGROUND: Ovarian cancer (OC) has high mortality and poor prognosis for lacking of specific biomarkers and typical clinical symptoms in the early stage. CEBPG is an important regulator in tumor development, yet it is unclear exactly how it contributes to the progression of OC. METHODS: TCGA and ti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xiaoqian, Zheng, Xiaocui, Ying, Xiang, Xie, Weiwei, Yin, Yujia, Wang, Xipeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199564/ https://www.ncbi.nlm.nih.gov/pubmed/37210575 http://dx.doi.org/10.1186/s12967-023-04136-0

Ejemplares similares

OCT4 induces EMT and promotes ovarian cancer progression by regulating the PI3K/AKT/mTOR pathway
por: Xie, Weiwei, et al.
Publicado: (2022)

CEBPG Exhibits Allele-Specific Expression in Human Bronchial Epithelial Cells
por: Blomquist, Thomas M., et al.
Publicado: (2013)

PARP inhibition promotes ferroptosis via repressing SLC7A11 and synergizes with ferroptosis inducers in BRCA-proficient ovarian cancer
por: Hong, Ting, et al.
Publicado: (2021)

ATF3 promotes ferroptosis in sorafenib-induced cardiotoxicity by suppressing Slc7a11 expression
por: Li, Yilan, et al.
Publicado: (2022)

CEBPG promotes acute myeloid leukemia progression by enhancing EIF4EBP1
por: Jiang, You, et al.
Publicado: (2021)

CEBPG transcription factor correlates with antioxidant and DNA repair genes in normal bronchial epithelial cells but not in individuals with bronchogenic carcinoma
por: Mullins, D'Anna N, et al.
Publicado: (2005)

Metformin induces Ferroptosis by inhibiting UFMylation of SLC7A11 in breast cancer
por: Yang, Jingjing, et al.
Publicado: (2021)

HBx facilitates ferroptosis in acute liver failure via EZH2 mediated SLC7A11 suppression
por: Liu, Guo-Zhen, et al.
Publicado: (2021)

Tetrandrine citrate suppresses lung adenocarcinoma growth via SLC7A11/GPX4-mediated ferroptosis
por: Mo, Xiaocong, et al.
Publicado: (2023)

Arbutin alleviates fatty liver by inhibiting ferroptosis via FTO/SLC7A11 pathway
por: Jiang, Tianyu, et al.
Publicado: (2023)

SLC7A11 as a Gateway of Metabolic Perturbation and Ferroptosis Vulnerability in Cancer
por: Lee, Jaewang, et al.
Publicado: (2022)

SLC7A11, a Potential Therapeutic Target Through Induced Ferroptosis in Colon Adenocarcinoma
por: Cheng, Xin, et al.
Publicado: (2022)

STAT6 inhibits ferroptosis and alleviates acute lung injury via regulating P53/SLC7A11 pathway
por: Yang, Youjing, et al.
Publicado: (2022)

LncRNA HEPFAL accelerates ferroptosis in hepatocellular carcinoma by regulating SLC7A11 ubiquitination
por: Zhang, Baofu, et al.
Publicado: (2022)

The ubiquitin hydrolase OTUB1 promotes glioma cell stemness via suppressing ferroptosis through stabilizing SLC7A11 protein
por: Zhao, Xinde, et al.
Publicado: (2021)

C8orf76 Modulates Ferroptosis in Liver Cancer via Transcriptionally Up-Regulating SLC7A11
por: Li, Duguang, et al.
Publicado: (2022)

Lidocaine Promoted Ferroptosis by Targeting miR-382-5p /SLC7A11 Axis in Ovarian and Breast Cancer
por: Sun, Dan, et al.
Publicado: (2021)

TXNDC12 knockdown promotes ferroptosis by modulating SLC7A11 expression in glioma
por: Yu, Hao, et al.
Publicado: (2023)

miR-16-5p Regulates Ferroptosis by Targeting SLC7A11 in Adriamycin-Induced Ferroptosis in Cardiomyocytes
por: Chen, Yongquan, et al.
Publicado: (2023)

METTL9-SLC7A11 axis promotes hepatocellular carcinoma progression through ferroptosis inhibition
por: Bi, Fangfang, et al.
Publicado: (2023)

Long noncoding RNA CASC11 suppresses sorafenib-triggered ferroptosis via stabilizing SLC7A11 mRNA in hepatocellular carcinoma cells
por: Chen, Fei, et al.
Publicado: (2023)

SLC7A11 regulated by NRF2 modulates esophageal squamous cell carcinoma radiosensitivity by inhibiting ferroptosis
por: Feng, Lei, et al.
Publicado: (2021)

Histone demethylase KDM3B protects against ferroptosis by upregulating SLC7A11
por: Wang, Yishu, et al.
Publicado: (2020)

Nrf2 attenuates ferroptosis-mediated IIR-ALI by modulating TERT and SLC7A11
por: Dong, Hui, et al.
Publicado: (2021)

PHGDH Inhibits Ferroptosis and Promotes Malignant Progression by Upregulating SLC7A11 in Bladder Cancer
por: Shen, Liliang, et al.
Publicado: (2022)

Capsaicin induces ferroptosis of NSCLC by regulating SLC7A11/GPX4 signaling in vitro
por: Liu, Xiao-Yan, et al.
Publicado: (2022)

SOCS2-enhanced ubiquitination of SLC7A11 promotes ferroptosis and radiosensitization in hepatocellular carcinoma
por: Chen, Qianping, et al.
Publicado: (2022)

IMCA Induces Ferroptosis Mediated by SLC7A11 through the AMPK/mTOR Pathway in Colorectal Cancer
por: Zhang, Lei, et al.
Publicado: (2020)

Bavachin Induces Ferroptosis through the STAT3/P53/SLC7A11 Axis in Osteosarcoma Cells
por: Luo, Yi, et al.
Publicado: (2021)

Hypoxia blocks ferroptosis of hepatocellular carcinoma via suppression of METTL14 triggered YTHDF2‐dependent silencing of SLC7A11
por: Fan, Zhuoyang, et al.
Publicado: (2021)

MITD1 Deficiency Suppresses Clear Cell Renal Cell Carcinoma Growth and Migration by Inducing Ferroptosis through the TAZ/SLC7A11 Pathway
por: Zhang, Ye, et al.
Publicado: (2022)

Rotavirus-induced lncRNA SLC7A11-AS1 promotes ferroptosis by targeting cystine/glutamate antiporter xCT (SLC7A11) to facilitate virus infection
por: Banerjee, Shreya, et al.
Publicado: (2023)

PUM2 aggravates the neuroinflammation and brain damage induced by ischemia–reperfusion through the SLC7A11-dependent inhibition of ferroptosis via suppressing the SIRT1
por: Liu, Qingran, et al.
Publicado: (2022)

Corrigendum to “IMCA Induces Ferroptosis Mediated by SLC7A11 through the AMPK/mTOR Pathway in Colorectal Cancer”
por: Zhang, Lei, et al.
Publicado: (2020)

ABCC5 facilitates the acquired resistance of sorafenib through the inhibition of SLC7A11-induced ferroptosis in hepatocellular carcinoma
por: Huang, Wenbin, et al.
Publicado: (2021)

Ferroptosis is involved in the progression of hepatocellular carcinoma through the circ0097009/miR-1261/SLC7A11 axis
por: Lyu, Ning, et al.
Publicado: (2021)

HSDL2 knockdown promotes the progression of cholangiocarcinoma by inhibiting ferroptosis through the P53/SLC7A11 axis
por: Ma, Shuoshuo, et al.
Publicado: (2023)

Temozolomide toxicity operates in a xCT/SLC7a11 dependent manner and is fostered by ferroptosis
por: Sehm, Tina, et al.
Publicado: (2016)

Nrf2 and STAT3 Alleviates Ferroptosis-Mediated IIR-ALI by Regulating SLC7A11
por: Qiang, Zhuanzhuan, et al.
Publicado: (2020)

SLC7A11 Reduces Laser-Induced Choroidal Neovascularization by Inhibiting RPE Ferroptosis and VEGF Production
por: Zhao, Xiaohuan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_agcj60lbv2lfiq87m60juupk55